Even though people of all ages with different degrees of vision loss are affected by the negative consequences of inaccessible drug labeling information, there are currently no federal or state requirements for the format of information on prescription labels.
"While some assistive devices can help people with vision loss manage medications, these technologies are not widely available," said Stacy Kelly, Ed.D., Policy Research Associate, AFB. "It is our hope that as Congress takes up healthcare reform legislation this year, one of its priorities will be to ensure that prescription drug labels and instructions are accessible to people with vision loss."
For the full report, including other personal stories, visit www.afb.org/druglabelreport.
The American Foundation for the Blind (AFB) is a national nonprofit that expands possibilities for people with vision loss. AFB's priorities include broadening access to technology; elevating the quality of information and tools for the professionals who serve people with vision loss; and promoting independent and healthy living for people with vision loss by providing them and their families with relevant and timely resources. AFB is also proud to house the Helen Keller Archives and honor the more than forty years that Helen Keller worked tirelessly with AFB. For more information visit us online at www.afb.org.
AFB has embarked on the Rx Label Enable campaign to ensure that people with vision loss have ready access to the vital information available to all consumers via prescription labeling and consumer medication information, enabling them to take medications safely, effectively, and independently. AFB is reaching out to all stakeholders, including consumers experiencing vision loss, policymakers, federal regulators
'/>"/>
| SOURCE American Foundation for the Blind Copyright©2009 PR Newswire. All rights reserved |